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ABSTRACT
In mammals, the Nogo family consists of Nogo-A,
Nogo-B and Nogo-C. However, there are three
Rtn-4/Nogo-related transcripts were identified in
zebrafish. In addition to the common C-terminal
region, the N-terminal regions of Rtn4-n/Nogo-C1,
Rtn4-m/Nogo-C2 and Rtn4-l/Nogo-B, respectively,
contain 9, 25 and 132 amino acid residues. In this
study, we isolated the 50-upstream region of each
gene from a BAC clone and demonstrated that the
putative promoter regions, P1-P3, are functional in
cultured cells and zebrafish embryos. A transgenic
zebrafish Tg(Nogo-B:GFP) line was generated using
P1 promoter region to drive green fluorescent
protein (GFP) expression through Tol2-mediated
transgenesis. This line recapitulates the endogen-
ous expression pattern of Rtn4-l/Nogo-B mRNA in
the brain, brachial arches, eyes, muscle, liver and
intestines. In contrast, GFP expressions by P2 and
P3 promoters were localized to skeletal muscles of
zebrafish embryos. Several GATA and E-box motifs
are found in these promoter regions. Using
morpholino knockdown experiments, GATA4 and
GATA6 were involved in the control of P1 promoter
activity in the liver and intestine, while Myf5 and
MyoD for the control of P1 and P3 promoter
activities in muscles. These data demonstrate that
zebrafish Rtn4/Nogo transcripts might be generated
by coupling mechanisms of alternative first exons
and alternative promoter usage.
INTRODUCTION
The inability of mammalian central nervous system (CNS)
axons to regenerate after spinal cord injury can partly be
attributed to inhibitory proteins associated with CNS
myelin (1,2). These myelin proteins include Nogo,
myelin-associated glycoprotein and oligodendrocyte
myelin glycoprotein (3). The human nogo gene encodes
three isoforms, termed Nogo-A, -B and -C, by alternative
promoter usage and alternative RNA splicing. All three
isoforms share a common C-terminal region composed of
two transmembrane domains and an extracellular domain
with a short 66-amino acid (aa) residue (Nogo-66), which
binds to the Nogo-66 receptor (4). The human Nogo-A
protein is the longest variant and contains three regions:
the N-terminal 1–180 aa, the middle 181–1004 aa
(NogoA-speciﬁc) and the C-terminal 1005–1192 aa con-
taining the Nogo-66 domain. Nogo-B is an isoform
lacking 181–1004 aa of Nogo-A, while Nogo-C lacks
residues 1–1004 and has an extra 12-aa residue at the
N-terminus.
Currently, Nogo-A is a known myelin-associated inhibi-
tor of axonal regeneration after spinal injury (5), whereas
Nogo-B was suggested to play important roles in
the control of tumor progression (6,7) as well as regulating
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about the function of Nogo-C. Moreover, a human
Nogo-B was demonstrated to bind to a new receptor,
NgBR, which is expressed in endothelial cells (9).
Although Nogo-B is not essential for normal vessel devel-
opment, local overexpression of Nogo-B elicited a beneﬁ-
cial eﬀect on vascular injury-induced neointimal
expansion (10).
In contrast to mammals, many axons in zebraﬁsh
regrow in the CNS after a lesion (11). Although growth
cones of goldﬁsh retinal axons can cross ﬁsh CNS myelin,
they collapse when they come in contact with mammalian
CNS myelin. These data suggest that ﬁsh axons recognize
neurite growth inhibitors associated with mammalian
CNS myelin, such as Nogo-A, but ﬁsh CNS myelin is
devoid of such inhibitors (12). The absence of the
Nogo-A gene in the zebraﬁsh genome was reported (13).
Three zebraﬁsh Rtn4/Nogo-related transcripts were
cloned (13–15). They were ﬁrst named Rtn4-l, Rtn4-m
and Rtn4-n (13), followed by other names, Nogo-a,
Nogo-b and Nogo-g (14). They have identical
C-terminal regions of 187 aa, which contain two trans-
membrane domains and one Nogo-66 domain and show
high degrees of aa identity to human and rat Nogo-related
proteins. The variable N-terminal regions of zebraﬁsh
Rtn4/Nogo-related proteins contain 132-, 25- and 9-aa
residues, respectively. Indeed, Rtn4-l and Nogo-a are
homologous to human and mouse Nogo-B with 43%
identity, while Rtn4-m/Nogo-b and Rtn4-n/Nogo-g are
homologous to mammalian Nogo-C. Thus, there are
two isoforms of Nogo-C in zebraﬁsh. The short form
can be called Rtn4-n/Nogo-g/Nogo-C1, while the long
form can be called Rtn4-m/Nogo-/Nogo-C2.
Moreover, these transcript variants use diﬀerent trans-
lation start sites, and have distinct expression patterns of
transcripts. The Rtn4-l/Nogo-B and Rtn4-n/Nogo-C1 tran-
scripts were expressed ubiquitously in all tissues examined.
The Rtn4-m/Nogo-C2 mRNA was also expressed in all
tissues except for the ovary, but was more abundant in
the muscle. During development, the Rtn4-l/Nogo-B
mRNA was expressed in eye, midbrain, brachial arch,
muscle, liver and intestine, while Rtn4-m/Nogo-C2
mRNA was present in forebrain, midbrain, hindbrain,
brachial arch, muscle and intestine (13–15). These data
suggest that the expressions of alternative splice variants
of Rtn4/Nogo genes can be diﬀerentially regulated by al-
ternative promoters. Currently, little is known about
coupling mechanisms of alternative ﬁrst exons and alter-
native promoter usage in zebraﬁsh Rtn4/Nogo genes.
Herein, we report the isolation and characterization of
three alternative promoters of zebraﬁsh Rtn4/Nogo
genes. The results of the luciferase analysis in cultured
cells and transgenic zebraﬁsh expressing the green ﬂuores-
cent protein (GFP) driven by their upstream regions
revealed that these three alternative promoters are bio-
logically functional. Thus, the expressions of zebraﬁsh
Rtn4/Nogo transcripts might also be regulated by alterna-
tive splicing coupled with the use of alternative promoters,
which is similar to the transcriptional regulation of mam-
malian Nogo genes.
MATERIALS AND METHODS
Cell cultures
Monkey kidney ﬁbroblast COS-1 cells and mouse muscle
myoblast C2C12 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium, supplemented with 10% fetal
bovine serum (HyClone, UT, USA), penicillin G
(50Uml
 1), streptomycin (50mgml
 1) and L-glutamine
(2mM) in a humidiﬁed atmosphere of 5% CO2 at 37 C.
Fish
Zebraﬁsh were raised and maintained under standard con-
ditions. Embryos were incubated at 28 C, and diﬀerent
developmental stages were determined according to the
description in the Zebraﬁsh Book (16).
Cloning of the P1, P2 and P3 promoter regions of
Nogo-related genes
All three promoter regions were ampliﬁed by a polymerase
chain reaction (PCR) using the BAC clone,
DKEY-103K8, as a template. Three primer sets, 50-GGT
ACCAAGCTTTGATTTGGTTAATTGTAA-30 and 50-G
TCGACAGAAACG TTATTTTAAAG-30,5 0-GGTACC
AGATCTCAAAAACTGCTTTAAAAA-30 and 50-GTC
GACCGGTCATATATCCAGTCAGGGGTC-30, and
50-GGTACCAGATCTGTGTAAAAAGGTCTGCCG-30
and 50-GTCGACCTGCGATCAGACAGCCTG GGCC
AA-30 were, respectively, used to amplify the P1 region
( 4885 to  13), the P2 region ( 3230 to  1) and the P3
region ( 3014 to  1). The forward and reverse primers,
respectively, contained KpnI and SalI sites. The PCR
product was digested with KpnI and SalI and cloned
into the pGL3-Basic vector (Promega, Madison, WI,
USA). Other deletion constructs from P1, such as
 3028/ 13,  2617/ 13,  2028/ 13 and  782/ 13 were
similarly generated by a PCR using primers as follows:
 3028, 50-GGTACCGCGCAGTAGGTAGTGCTGTT
GCCTCACA-30;  2617, 50-GGTACCCTGCAGAACC
GGTTTGGTACTTTACGTC-30;  2028, 50-GGTACCT
AATTAATCAGGGGTCACCACAGTGGAA-30; and
 782, 50-GGTACCGGGCCCCATAGCTGGATTGCT
TAGGGCC-30. Similarly, other deletion constructs from
P2 ( 2564/ 1 and  1213/ 1) (as follows:  2564, 50-GGT
ACCTCGCGACAACATAATTAATTCCACTTTG-30
and  1213, 50-GGTACCTTAATTAATTTTTTTTAAG
AAAGAAACT-30) and P3 ( 1292/ 1 and  757/ 1) (as
follows:  1292, 50-GGTACCATTTAAATTGATCAAA
AGTGACATGCAA-30 and  757, 50-GGTACCTTAAT
TAAA GCCAGTCTTACCTCAATGC-30) were similarly
generated by a PCR with suitable primer sets containing
the KpnI and SalI sites.
To construct the GFP reporter plasmids, a similar
strategy was used as described above for the luciferase
reporter constructs except using primers carrying the
SalI and ApaI sites. PCR products were digested with
Sal I and Apa I, and subcloned into the pT2KXIGin
vector digested with the same restriction enzyme sets (17).
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promoter region
Putative transcription factor binding sites in the P1, P2
and P3 promoter regions were identiﬁed by the
TRANSFAC 6.0 data base using Transcription Element
Search Software (18).
Transactivation assay
Transfections were performed in 12-well plates. One
microgram of promoter DNA and 0.5mgo fa
pSV-b-galactosidase were transfected using a
Lipofectamine kit (Invitrogen Life Technologies, CA,
USA) into COS-1 or C2C12 cells. Cells were harvested
at 48 h after transfection and assayed for luciferase and
b-galactosidase activity using a kit from Promega.
Luciferase activity was normalized to b-galactosidase
activity in cell lysates and expressed as an average of
three independent experiments.
Microinjection of expression constructs into zebraﬁsh
embryos
The reporter plasmids were linearized, and DNA concen-
trations were adjusted to 100mgml
 1 in a 0.1 M KCl
solution containing 0.5% phenol red. Microinjection and
image capture were performed as described before (19).
Injected embryos were observed by ﬂuorescence
microscopy.
To obtain stable transgenic ﬁsh, embryos at the one-cell
stage were co-injected with 10 ngml
 1 of either P1( 4885/
 13)-GFP or P3( 3014/ 1)-GFP or P3( 1292/ 1)-GFP
plasmid, 5 ngml
 1 of capped Tol2 transposase mRNA and
0.1% phenol red as previously described (20). The pCS-TP
plasmid (21) encoding the transposase was linearized with
NotI and used as a template for in vitro transcription
withmMessagemMachine (Ambion, Foster City, CA,
USA), according to the manufacturer’s instructions.
To generate germline transgenic zebraﬁsh, the injected
embryos were raised to adulthood and 3-month-old ﬁsh
(F0) was crossed to wild-type ﬁsh. F1 embryos were
examined by ﬂuorescence microscopy to identify
germline-transmitted F0 founders. Positive F1 embryos
were raised to adulthood and were then screened in the
same way to estimate copy numbers of the transgene
and to establish stable transgenic lines. Three independ-
ent lines (F2 and more advanced generations) were
obtained.
Morpholino injections
Respective morpholino oligonucleotides (MOs) were
synthesized by Gene Tools (Philomath, OR, USA). The
MO was dissolved in Danieau solution containing 0.5%
phenol red to 0.3mM and 3.2 ng per embryo was injected
into embryos at the one- to two-cell stage. MO sequences
are: myod,5 0-ATATCCGACAACTCCATCTTTTTTG
-30; myf5,5 0-TCTGGGATGTGGAGAATACGTCCAT
-30; GATA4, 50-TCCACAGGTGAGCG A TTATTGCT
CC-30 and GATA6, 50-CGATGGCCAGGGTCTGATA
CATGTC-30.
In situ hybridization
Digoxigenin-labelled antisense RNA probes were
generated by in vitro transcription using linearized
Rtn4-l/Nogo-B, Rtn4-n/Nogo-C1 and Rtn4-m/Nogo-C2
plasmids as templates. Whole-mount in situ hybridization
was performed as previously described (19). Speciﬁc
primers for Nogo-B (50-GTTGAAACTGCTGCACTGT
CGTTCAC-30 and 50-GCACGAAGAGTTACATT TAT
ATGGCGC-30), Nogo-C1 (50-GGGACTTTTGTTTTGA
AATTTGACCGGA AC-30 and 50-CTTGTTTGGAATC
CATCTCGCTCATCTGCG-30), Nogo-C2 (50-GTCCTG
TCCTGCTCCAGCCAGAGAC-30 and 50-CCTGTTCT
TCCCAGTGTTTA ATCTCC-30), L-FABP (50-CACAG
GCTGATGGCGTTCACTGGGAAATAT-30 and 50-GC
TTTACAATCATGAGATGCGTCTGCTGAT-30),
i-FABP (50-TCTGTCA TCATCATGACCTTCAACGG
GACC-30 and 50-GATAACAGTTTAAGCCCTCT TGA
AAATCCT-30), GFP (50-CGTAAACGGCCACAAGTT
CAGCGTGTCCGG-30 and 50-GGCGGTCACGAACT
CCAGCAGGACCATGTG-30) were used to amplify
probe templates.
Cryosectioning and immunohistochemistry
Standard protocol was used for cryosectioning. Sections
of 30mm thick were cut and collected on a Leica CM1900
Cryostat (Leica, Wetzlar, Germany). Monoclonal
antibodies F59 (antislow MyHC; 1:10) and EB165
(antifast MyLC; 1:200) were obtained from
Developmental Studies Hybridoma Bank (University of
Iowa, IA, USA). Rabbit anti-GFP (1:200) was obtained
from Abcam (Cambridge, MA, USA). For brown
staining, embryos were incubated with peroxidase-tagged
secondary antirabbit antibodies (1:200) (BioRad,
Hercules, CA, USA) and stained with Fast DAB
(Sigma, CA, USA). Embryos were mounted between
cover slips for viewing and analysed using Zeiss
Axioplan 2 microscope (Thornwood, NY, USA).
RESULTS
Analysis of P1 promoter activity in cultured cells and
zebraﬁsh embryos
We used those Rtn4/Nogo complementary (c) DNAs as
bait to perform an online BLAST search of the GenBank
data base and matched nine non-contiguous regions in
219514 bp of the DKEY-103K8 zebraﬁsh BAC clone.
Subsequently, we compared sequences between this BAC
clone and each zebraﬁsh Rtn4/Nogo cDNA. The result
indicated that all three Rtn4/Nogo cDNAs were contained
within nine putative exons and eight introns spanning  27
kb. They had identical sequences derived from exons 2 to
7. The N-terminal regions of Rtn4-l/Nogo-a/Nogo-B,
Rtn4-m/Nogo-b/Nogo-C2 and Rtn4-n/Nogo-g/Nogo-C1
were, respectively, encoded by exons 1a, 1b and 1c.
The putative 50-upstream promoter regions of exons 1a,
1b and 1c were, respectively, designated P1, P2 and P3
(Figure 1).
Analysis of the P1 region ( 4885 to  13 relative to the
AUG translation initiation site of Rtn4-l/Nogo-B) revealed
Nucleic Acids Research, 2010,Vol.38, No. 14 4637numerous putative binding sites for transcription factors,
such as Nkx2.5, c-Ets-1, SP1, AP1, AP4 and GATA
(Figure 2A, panel c), 24 E-boxes (panel b) and four
myocyte enhancer factor 2 (MEF 2) motifs (panel d).
No typical TATA box was found. The P1 region,  4885
to  13, corresponded to nucleotides 72272–77144 of the
DKEY-103K8 BAC clone.
To test the activity of the P1 promoter in vitro, a large
fragment ( 4885 to  13) and four deletions were fused to
the luciferase reporter gene in the pGL3-Basic vector. As
shown in Figure 2B, the luciferase activity of
pGL3-P1( 4885/ 13) was about 2.5- and 2-fold higher
than those of pGL3-P1( 3028/ 13) in COS-1 and
C2C12 cells, respectively, suggesting that the distal
1.8-kb upstream region contained positive regulatory se-
quences in both cell types.
We also used zebraﬁsh embryos and a GFP reporter
gene to investigate the promoter activity in vivo (22).
As shown in Table 1, embryos injected with
P1( 4885/ 13)-GFP predominantly displayed GFP ex-
pression in muscles (81.7%) and skin (48.7%), moderately
in neurons (25.2%) and less so in the heart (12.2%),
circulating blood cells (13.0%) and notochord (4.4%).
One zebraﬁsh embryo injected with P1( 4885/ 13)-GFP
is presented (Figure 3, panels a and b) to show the GFP
signal in muscles, skin and heart. Embryos injected with
P1( 3028/ 13)-GFP and P1( 2028/ 13)-GFP displayed
similar GFP expression patterns to those embryos injected
with P1( 4885/ 13)-GFP, but with lower expression rates
(Table 1). These data are consistent with results of the
luciferase activity assay in cultured cells. Moreover, the
expression pattern in a variety of tissues of zebraﬁsh
embryos injected with P1( 3028/ 13) was similar to the
endogenous expression pattern of the Rtn4-l/
Nogo-/Nogo-B transcript, which is expressed in
the brain, eyes, muscles, brachial arches, liver and intes-
tines (14).
Expression pattern of Tg(Nogo-B: GFP) transgenic
zebraﬁsh recapitulates the Rtn4-l/Nogo-B expression
pattern in various organs including the liver and intestines
In order to validate the results of the in vitro analysis of
the P1 promoter in cultured cells and zebraﬁsh embryos,
we generated Tg(Nogo-B:GFP) transgenic zebraﬁsh by the
method of Tol2-mediated transgenesis (21,23). Only the
large fragment ( 4885 to  13) was cloned into a Tol2
expression vector containing the GFP reporter transgene
(17) and co-injected with Tol2 transposase mRNA into
one-cell zygotes. Embryos that exhibited mosaic GFP ex-
pression were raised to adulthood and out crossed to the
AB wild-type strain. GFP-positive F1 embryos were
identiﬁed, again were raised to adulthood, and used to
generate several stable transgenic lines. Among the three
transgenic ﬁsh lines generated, only the line possessing the
highest expression level, designated Tg(Nogo-B:GFP), was
used for further analysis.
GFP distribution patterns in a live Tg(Nogo-B:GFP)F 3
embryo at diﬀerent developmental stages are shown in
Figure 4A. In 1- and 2-day post-fertilization (dpf)
embryos, the GFP signal was observed in the brain, eye
and muscle (panels a, a’, b and b’). Starting at 3-dpf, high
levels of GFP expression were detected in the liver and
intestines which were sustained to 6-dpf (panels c, c’, d,
d’, e, e’, f and f’). The GFP signal was also detected in the
brachial arches (panels b, c, d, e and f).
We further performed in situ hybridization to investi-
gate whether the endogenous Rtn4-l/Nogo-/Nogo-B
mRNA was colocalized to the GFP expression site in the
corresponding organs. In 1-, 2-, 3-, 4-, 5- and 6-dpf
embryos (Figure 4B), Rtn4-l/Nogo-B mRNA was ex-
pressed in eye, midbrain, hindbrain, midbrain–hindbrain
boundary, brachial arch, muscle, liver and intestine.
Altogether GFP expression in the transgenic
Tg(Nogo-B:GFP) line recapitulated the endogenous ex-
pression pattern of Rtn4-l/Nogo-/Nogo-B mRNA (14).
Figure 1. Three Rtn4/Nogo-related transcripts were generated by alternative promoter usage and alternative RNA splicing. Genomic organization of
the zebraﬁsh Rtn4/Nogo gene was shown. Exons are indicated by boxes numbered 1–7. Solid boxes indicate the Rtn4/Nogo coding region, whereas
open boxes represent the 50- and 30-untranslated regions. Introns and the 50-ﬂanking regions are indicated by solid lines. All three isoforms have
identical sequences derived from exons 2 to 7 but not exon 1. Exon 1a was used for Rtn4-l/Nogo-B, exon 1b for Rtn4-m/Nogo-C2 and exon 1c for
Rtn4-n/Nogo-C1. The 50-upstream promoter regions of each exon 1 are, respectively, designated P1, P2 and P3.
4638 Nucleic Acids Research, 2010,Vol.38, No. 14Figure 2. Activity of the 50-upstream region of the P1 promoter in cultured cells. (A) Restriction map and possible transcription factor-binding
motifs in the P1 promoter ( 4885/ 13). (B) COS-1 and C2C12 cells were cotransfected with 1mg of each reporter construct and pSV-b-galactosidase,
respectively. Cell lysates were prepared at 48 h after transfection and subjected to a luciferase activity assay. pGL3-Basic was used as the negative
control.
Nucleic Acids Research, 2010,Vol.38, No. 14 4639Analysis of P2 and P3 promoter activities in cultured cells
and zebraﬁsh embryos
We also analysed the P2 ( 3230 to  1) and the P3
promoter regions ( 3014 to  1). There were several
putative transcription factor binding sites, such as
Nkx2.5, c-Ets-1, SP1, AP1, AP4 and GATA and 14
E-boxes present in each region (Figure 5A, B). In
addition, there are two and three MEF-2 binding motifs
in the P2 and P3 promoters (Figure 5A, panel d and
Figure 5B, panel h). The P2 promoter region ( 3230 to
 1) corresponded to nucleotides 77844–81073 of the
BAC clone, DKEY-103K8, while the P3 promoter
region ( 3014 to  1) corresponded to nucleotides
83588–86601 of the same BAC clone.
To test the activity of the P2 promoter in vitro, a large
fragment ( 3230 to  1) and two deletions, P2( 2564/ 1)
Figure 3. Activity of the 50-upstream region of the P1 promoter in zebraﬁsh embryos. P1(-4885/-13)-GFP was microinjected into zebraﬁsh embryos
at the one-cell stage. Zebraﬁsh embryos at 48-h post-fertilization (hpf) with GFP signals were selected for image analysis. Embryos are shown in
lateral view with the anterior to the left and dorsal to the top. H, heart; S, skin; M, muscle; N, neuron; NC, notochord. Scale bars represent 100
(panels a and b) and 20mm (panels c–j).
Table 1. Expression of GFP in zebraﬁsh embryos at 48-hpf injected with expression constructs containing diﬀerent regions of the Nogo-P1
promoter
Construct No. of
embryos
observed
No. of
embryos
with GFP
expression
No. of embryos with GFP expression in
circulating
blood cells (%)
heart (%) muscle (%) neurons (%) notochord (%) skin (%)
P1( 4885/ 13)-GFP 162 115 15 (13.0) 14 (12.2) 94 (81.7) 29 (25.2) 5 (4.4) 56 (48.7)
P1( 3028/ 13)-GFP 154 124 9 (7.3) 11 (8.9) 97 (78.2) 22 (17.7) 13 (10.5) 60 (48.4)
P1( 2028/ 13)-GFP 144 95 10 (10.5) 10 (10.5) 68 (71.6) 12 (12.6) 6 (6.3) 42 (44.2)
4640 Nucleic Acids Research, 2010,Vol.38, No. 14Figure 4. Expression patterns of the GFP in the transgenic zebraﬁsh Tg(Nogo-B:GFP) line. Microinjection of the expression construct,
P1( 4885/ 13)-GFP, into zebraﬁsh embryos at the one-cell stage and generation of a transgenic GFP line via Tol2-mediated transgenesis are
described in the text. (A) contains images from the Tg(Nogo-B:GFP) transgenic line at diﬀerent developmental stages. Merged bright ﬁeld and
ﬂuorescence images are shown in panels a’–d’, while ﬂuorescence images are shown in panels a–d.( B) Localization of Rtn4-l/Nogo-B mRNA in
Tg(Nogo-B:GFP) ﬁsh at diﬀerent developmental stages. ba, brachial arches; e, eyes; hb, hindbrain; i, intestine; l, liver; m, muscle; mhb, midbrain–
hindbrain boundary.
Nucleic Acids Research, 2010,Vol.38, No. 14 4641Figure 5. Activity of the 50-upstream regions of the P2 and P3 promoters in cultured cells. Restriction map and putative transcription factor-binding
motifs of the P2 ( 3230/ 1) (A) and P3 promoters ( 3014/ 1) (B) are shown. (C) Transfection of expression constructs into COS-1 and C2C12 cells
and luciferase activity were assayed in the same way as described in Figure 3.
4642 Nucleic Acids Research, 2010,Vol.38, No. 14and P2( 1213/ 1), were fused to the luciferase reporter
gene in the pGL3-Basic vector. Similarly, three expression
constructs, pGL3-P3( 3014/ 1), pGL3-P3( 1292/ 1)
and pGL3-P3( 757/ 1), were generated. As shown in
Figure 6A, the luciferase activities of pGL3-P2( 3230/
 1), pGL3-P2( 2564/ 1) and pGL3-P2( 1213/ 1)
were low in both COS-1 and C2C12 cells, but were signiﬁ-
cant compared to that of the control pGL3-Basic
construct. On the other hand, the luciferase activity
of pGL3-P3( 1292/ 1) was  3- and 2-fold higher
compared to those of pGL3-P3( 3014/ 1) and pGL3-
P3( 757/ 1) in COS-1 and C2C12 cells, respectively.
These data suggest that there are negative ( 3014
to  1292) and positive regulatory sequences ( 1292
to  757) present in the P3 promoter region.
We also tested the promoter activities of the P2 and P3
regions in zebraﬁsh. Embryos injected with P2( 3230/
 1)-GFP (Figure 6, panel a), P2( 1213/ 1)-GFP (panel
b), P3( 3014/ 1)-GFP (panel c) and P3( 1292/ 1)-GFP
(panel d) all mainly displayed GFP expression in muscles.
P3( 1292/ 1)-GFP-injected embryos had much stronger
GFP signals than those in P3( 3014/ 1)-GFP-injected
embryos, which is consistent with the luciferase activity
assay in cultured cells as shown in Figure 5C. However,
some GFP signals were observed in the skin. On the other
hand, the activity of the P2 promoter region was still very
weak in zebraﬁsh embryos, which was similar to that in
culture cells. For comparison, embryos injected with the
a-actin promoter (22) displayed strong GFP expression
speciﬁcally in muscles (panel e).
To further clarify which muscle type expressing GFP,
zebraﬁsh embryos were injected with P1( 4885/ 13)-
GFP, P3( 3014/ 1)-GFP and P3( 1292/ 1)-GFP, re-
spectively, and then analysed by using diﬀerent antibodies
against slow muscle (F-59), fast muscle (EB-165) and GFP
protein. As shown in Figure 6 B, the expression patterns
of GFP and fast muscle are similar, but are diﬀerent from
that of slow muscle, suggesting that the muscle type with
GFP belongs to fast muscle.
We also generated Tg(Nogo-C1:GFP) transgenic
zebraﬁsh by the method of Tol2-mediated transgenesis
(21,23). Only the large fragment ( 3014 to  1) was
Figure 6. Activity of the 50-upstream regions of the P2 and P3 promoters in zebraﬁsh embryos. (A) P2( 3230/ 1)-GFP, P2( 1213/ 1)-GFP,
P3( 3014/ 1)-GFP and P3( 1292/ 1)-GFP were separately microinjected into zebraﬁsh embryos at the one-cell stage. Zebraﬁsh embryos at
48-hpf with GFP signals were selected for image analysis. For comparison, embryos injected with the a-actin promoter (panel e) displayed strong
GFP expression speciﬁcally in muscles. Merged bright-ﬁeld and ﬂuorescence images are shown in panels a’–e’, while ﬂuorescence images are shown in
panels a–e. Scale bars indicate 100mm. (B) Zebraﬁsh embryos at 4 dpf mentioned above were subjected to cryosection and labelled with diﬀerent
antibodies as follow. The primary antibodies were mAb F59 (anti-MyHC, slow muscle) at 1: 20, mAb EB165 (anti-MyLC, fast muscle) at 1:200 and
rabbit anti-GFP at 1: 200 dilution. After washing, slides were incubated with peroxidase-tagged secondary antirabbit antibodies at 1:200 dilution
and stained with Fast DAB. (C) Expression patterns of GFP and Rtn4-n/Nogo-C1 in the transgenic zebraﬁsh Tg(Nogo-C1:GFP) line. Images were
taken from the Tg(Nogo-C1:GFP) transgenic line at 3 dpf. Merged bright-ﬁeld and ﬂuorescence images are shown in panel (a), while ﬂuorescence
images are shown in panel (a’). Expression of Rtn4-n/Nogo-C1 (panel b) and GFP (panel c) mRNA in the transgenic zebraﬁsh Tg(Nogo-C1:GFP) line
was analysed by whole-mount in situ hybridization. ba, brachial arches; e, eyes; i, intestine; m, muscle; mhb, midbrain-hindbrain boundary.
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reporter transgene (17) and co-injected with Tol2
transposase mRNA into one-cell zygotes. Embryos that
exhibited mosaic GFP expression were raised to adult-
hood and out-crossed to the AB wild-type strain. The
GFP signal in F1 embryo at 3-dpf was observed in
muscle, midbrain–hindbrain boundary, eye and brachial
arch (Figure 6C, panel a). In addition, the expression of
GFP in Tg(Nogo-C1:GFP) was compared with the en-
dogenous Rtn4-n/Nogo-C1 expression by whole-mount
in situ hybridization (panels b and c). Their expression
patterns are similar in muscle, eye and brachial arch.
However, only GFP signal was detected in intestine and
midbrain–hindbrain boundary. No Rtn4-n/Nogo-C1 ex-
pression was observed in these two regions. This diﬀerence
may be attributed to the short length of speciﬁc Rtn4-n/
Nogo-C1 probe, which is only 120 bp.
GATA4 and GATA6 are required for P1 promoter
activities in the liver and intestine, while Myf5 and MyoD
are important for P1 and P3 promoter activities in
muscles
In zebraﬁsh embryo, myod and myf5 are required for in-
duction of myogenesis. It has been reported that either
myf5 or myod is suﬃcient to promote slow muscle forma-
tion from adaxial cells, and that myod is required for fast
muscle diﬀerentiation (24,25). Recently, at least three
groups used myf5/myod double-morphant embryos to
study muscle development (26–28). As shown in
Figure 7A, we found that myf5/myod double morphants
abolished the GFP expression in muscles driven by either
P1 or P3 promoters (panels b, d, f and h). Moreover, the
expression of GFP in the muscle of wild-type or myf5/
myod double morphants was further analysed by
whole-mount in situ hybridization (Figure 7B). There is
no GFP signal in myf5/myod double morphants (panels
a’, b’ and c’), suggesting that Myf5 and MyoD are import-
ant for the P1 and P3 promoter activities.
As shown in Figure 2A, panel c, there are nine GATA
binding motifs in the P1 promoter region. In order to in-
vestigate whether GATA factors can regulate the P1
promoter activities, we injected both GATA4-MO and
GATA6-MO into zebraﬁsh embryos of transgenic
Tg(Nogo-B:GFP) line at one- to two-cell stage. The
GATA4/GATA6 double morphants showed very low
GFP expression in the liver and intestine (Figure 7C).
Taken together, GATA4 and GATA6 are involved in the
control of P1 promoter activity in the liver and intestine,
while Myf5 and MyoD are important for the control of P1
and P3 promoter activities in muscles.
DISCUSSION
In this study, we demonstrate that those three Rtn-4/Nogo
transcripts may be generated by alternative promoter
usage and alternative RNA splicing. These data are con-
sistent with the mammalian counterparts, which consist of
Nogo-A, Nogo-B and Nogo-C.
In humans, the Nogo-A transcript was shown to pref-
erentially be expressed in oligodendrocytes and some CNS
neuronal cells as studied by in situ hybridization using a
Nogo-A-speciﬁc probe. However, the Nogo-C transcript
is also expressed at a high level in skeletal muscles, and
small amounts of Nogo-B and -C transcripts were
detected in the kidneys and lungs (29). Similarly, the
zebraﬁsh Rtn-4l/Nogo-B transcript is ubiquitously ex-
pressed in many tissues including the brain, liver, intes-
tines, eyes and muscles (14), while Rtn-4n/Nogo-C2 and
Rtn-4m/Nogo-C1 are predominantly expressed in muscles
(13).
In mammals, the 50-upstream 2.8- and 3.3-kb portions
of the human Nogo P1 and P2 promoter regions were
characterized in a variety of cultured cells (15). The
Nogo P1 promoter is used for the transcription of
human Nogo-A and Nogo-B, while the Nogo P2
promoter is used for the transcription of human
Nogo-C. The promoter activity of P1 was strong in all
transfected cells including COS-7, 3T3 and C2C12 cells.
However, the activity of the P2 promoter was weak in
both Nogo-Cexpressing and Nogo-C-non-expressing
cells. Similarly, the promoter activity of zebraﬁsh P1 was
stronger than those of P2 and P3 in both COS-1 and
C2C12 cells (Figures 4C and 6C). Moreover, when
P1( 4885/ 13)-GFP was injected into zebraﬁsh embryos
at the one-cell stage, GFP signals were observed in a
variety of tissues in embryos at 72 hpf (Figure 5). In
contrast, embryos injected with P2( 3230/ 1)-GFP or
P2( 1213/ 1)-GFP displayed weak GFP signals, but
they were speciﬁc in skeletal muscles (Figure 6).
Similarly, embryos injected with either P3( 3014/ 1)-
GFP or P3( 1292/ 1)-GFP also showed strong GFP
signals in muscles (Figure 6).
The consensus sequence of the E-box is CANNTG. This
binding motif is recognized by myogenic regulatory
factors (30). Multiple E-boxes were found in promoters
of muscle-speciﬁc genes including creatine kinase,
myosin light chain and myogenin (31,32). In this study,
we found that there were 24, 14 and 14 E-boxes present in
the 50-upstream regions of the P1, P2 and P3 promoters,
respectively. In the case of the P1 promoter, zebraﬁsh
embryos injected with P1( 4885/ 13)-GFP predominant-
ly displayed GFP expression in muscle ﬁbers (81.7%)
(Table 1). However, embryos injected with either
P2( 3230/ 1)-GFP, P2( 1213/ 1)-GFP, P3( 3014/
 1)-GFP or P3( 12920/ 1)-GFP all mainly displayed
GFP expression in muscles (Figure 6). Analysis of the
P3 promoter region ( 3014 to  1) indicated that two
E-boxes are located in the proximal 550-bp region, while
10 sites are in the distal 2464-bp region. As shown in
Figure 6, P3( 1292/ 1)-GFP had stronger GFP expres-
sion in muscles, while P3( 3014/ 1)-GFP had lower GFP
expression in muscles. Determining the relevance of
promoter activity to the presence of potential regulatory
E-box elements in the 50-ﬂanking region of the P3
promoter requires further mutation analysis. On the
other hand, the GFP signal in muscles either driven by
P1 or P3 promoters in myf5/myod double-morphants
could not be detected (Figure 7A and B). These data
suggest that the E-box binding transcription factors,
Myf5 and MyoD, are important for the regulation of P1
and P3 promoter activities.
Nucleic Acids Research, 2010,Vol.38, No. 14 4645Figure 7. Loss of MyoD and Myf5 ablates somatic fast muscle and knockdown of GATA4 and GATA6 results in loss of GFP signal in the liver and
intestine. (A) P1( 4885/ 13)-GFP, P3( 3014/ 1)-GFP and P3( 1292/ 1)-GFP were separately injected or each coinjected with myod/myf5 double
MOs into zebraﬁsh embryos at the one-cell stage. Alternatively, myod/myf5 double MOs were injected to the transgenic Tg(Nogo-B:GFP) line at the
one-cell stage. Zebraﬁsh embryos at 48 hpf with GFP signals were selected for image analysis. Merged bright-ﬁeld and ﬂuorescence images are shown
in panels (a’–h’), while ﬂuorescence images are shown in panels (a–h). Scale bars indicate 100mm. (B) Those embryos mentioned above at 3 dpf were
subjected to whole-mount in situ hybridization using GFP as probe. All myod/myf5 double morphants did not show GFP signal. (C) GATA4/GATA6
double MOs were injected into zebraﬁsh embryos of transgenic Tg(Nogo-B:GFP) line at one- to two-cell stage. The GATA4/GATA6
double-morphants and the parental transgenic line at 4 dpf were subjected to whole-mount in situ hybridization using GFP (panels a and b) and
LFABP/iFABP (panels c and d) as probe. The liver and intestine were enlarged in panels (a’–d’).
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ant roles in linking calcium-dependent signaling pathways
to the genes responsible for cell division and diﬀerenti-
ation. The MADS domain in MEF2 family proteins
mediates dimerization and binding to the DNA sequence
CTA(A/T)4TAG/A (33). MEF2 factors associate with a
variety of transcriptional cofactors to control speciﬁc
sets of downstream target genes. The interaction
between MEF2 and MyoD is involved in the regulation
of the skeletal muscle diﬀerentiation. Four MEF2
isoforms (A–D) have been identiﬁed in mammals, and
all except MEF2B are expressed in skeletal muscle (34).
In zebraﬁsh, there are three members in MEF2 family
(35). In this study, there are four, two and three MEF-2
binding motifs in the P1, P2 and P3 promoters, respect-
ively. The functional roles of these MEF-2 binding motifs
in the regulation of the P1, P2 and P3 promoters need
further investigation.
Although there is only one Nogo-C protein in
mammals, an artiﬁcial fusion protein of the human
Amino-NogoA-24 domain and Nogo-66 was generated
which had higher Nogo receptor binding (36).
Structurally, this fusion protein is similar to zebraﬁsh
Rtn4-n/Nogo-C1 and Rtn4-m/Nogo-C2, with 67 and
64% identities, at the level of aa sequences. The
Nogo-A-24 domain was mapped to the region of 995–
1018 aa of Nogo-A. The fusion proteins of human
Nogo-A-24 and Nogo-66 contain 198 aa, while zebraﬁsh
Rtn-4m/Nogo-C1 contains 196 aa. Both human
Nogo-A-24 and Nogo-66 domains can bind to the Nogo
receptor, NgR. Whether zebraﬁsh Rtn4-n/Nogo-C1 and
Rtn4-m/Nogo-C2 are functionally related to this fusion
protein remains to be further investigated by ligand- and
receptor-binding assays. In zebraﬁsh, there are four Nogo
receptors, NgR, NgRH1a, NgRH1b and NgRH2 (37). By
in situ hybridization, all Nogo receptor transcripts were
expressed in the brain including forebrain, midbrain and
hindbrain, but there was no signal present in the muscle of
zebraﬁsh embryos (unpublished data). It seems that
Rtn4-n/Nogo-C1 and Rtn4-m/Nogo-C2 may not interact
with any of those four Nogo receptors in the muscle.
Analysis of the upstream 4.8-kb promoter region of the
zebraﬁsh Rtn4-l/Nogo-B gene revealed the existence of
many binding motifs for transcription factors such as
Nkx2.5, c-Ets-1, SP1, AP1, AP4, GATA and E-box
(Figure 2A). Interestingly, a group of GATA, MyoD/
E-box and Nkx motifs has been reported to involve in
the regulation of mouse fetoprotein transcription factor
gene promoter (38). In addition, the promoter activity of
the mouse alpha3 integrin gene was regulated by a group
of c-Ets-1, GATA and Myo-D/E-box motifs (39). Such a
group could be also found in P1 promoter. As shown in
Figure 7, GATA4, GATA6, Myf5 and MyoD play import-
ant roles in the regulation of P1 promoter activities. The
functional role of c-Ets-1 in the regulation of P1 promoter
awaits further investigation.
The presence of nine GATA-binding sites in the
zebraﬁsh Rtn4-l/Nogo-B gene promoter suggests that the
Gata4/Gata5/Gata6 transcription factor possibly regu-
lates Rtn4-l/Nogo-B gene expression in the liver and intes-
tines. In zebraﬁsh, Gata4 regulates the formation of
multiple organs including the liver (40), while Gata5 is
also essential for gut morphogenesis and liver develop-
ment (41,42). In the mouse, Gata6 is essential for embry-
onic development of the liver (43). In this study, we
injected both GATA4-MO and GATA6-MO into zebraﬁsh
embryos of transgenic Tg(Nogo-B:GFP) line and found
that the GATA4/GATA6 double morphants displayed
very low GFP expression in the liver and intestine
(Figure 7C), suggesting that GATA4 and GATA6 are
involved in the control of P1 promoter activity in the
liver and intestine.
In mammals, Nogo-A and Nogo-C are highly expressed
in the CNS, while Nogo-B is ubiquitously expressed in
many tissues, including the central and peripheral
nervous systems, spleen, skeletal muscles, heart and
vessel walls (15,44). A previous study indicated that
zebraﬁsh Rtn4-l/Nogo-B is also expressed in many tissues
including the brain, eyes, muscles, branchial arches, liver
and intestines during diﬀerent developmental stages (14).
It is interesting to note that the 4.8-kb promoter of Rtn4-l/
Nogo-B has the ability to drive GFP expression in these
organs (Figure 4). In addition to this Tg(Nogo-B:GFP)
line, other transgenic zebraﬁsh lines exhibited GFP expres-
sion in the liver or intestines or both. The 2.8-kb
50-ﬂanking sequence of the zebraﬁsh L-FABP gene is suf-
ﬁcient to direct GFP expression in the liver (45), while the
4.5-kb promoter region of zebraﬁsh I-FABP gene can
drive GFP expression in the intestines (46).
Morphogenesis of the liver and intestines can be visualized
in the Tg(GATA6:GFP) transgenic line, which expresses
GFP in both organs (40). Gata6 gene expression was pre-
viously associated with endoderm-derived organs, and a
mouse knockout model showed speciﬁc functions for
GATA6 in the visceral endoderm (47). On the other
hand, mammalian fatty acid-binding proteins are small
cytosolic proteins present in various tissues including the
liver, intestines, brain and heart, which play important
roles in intracellular fatty acid traﬃcking and metabolism
(48–52). In this study, we demonstrated that the expres-
sion of zebraﬁsh Rtn4-l/Nogo-B in the liver and intestine
was mediated by GATA proteins to regulate its promoter
activity and speciﬁcity (Figure 7). So far, there is no
evidence to indicate that Rtn4-l/Nogo-B plays any role in
the morphogenesis of the liver and intestine.
ACKNOWLEDGEMENTS
We are grateful to Professor Huai-Jen Tsai and
Dr Chiou-Hwa Yuh for providing us with myod/myf5
MOs and GATA4/GATA6 MOs, respectively, for testing.
We thank Wei-Hao Liao, Kuan-Ya Liao, Shan Su and
Chung-Hsiang Yang for technical assistance.
FUNDING
Academia Sinica, Taipei, Taiwan, grant (AS-95-TP-B02).
Funding for open access charge: Institute of Biological
Chemistry, Academia Sinica, Taipei, Taiwan.
Conﬂict of interest statement. None declared.
4648 Nucleic Acids Research, 2010,Vol.38, No. 14REFERENCES
1. Filbin,M.T. (2003) Myelin-associated inhibitors of axonal
regeneration in the adult mammalian CNS. Nat. Rev. Neurosci.,
4, 703–713.
2. Schwab,M.E. (2004) Nogo and axon regeneration. Curr. Opin.
Neurobiol., 14, 118–124.
3. Yiu,G. and He,Z. (2003) Signaling mechanisms of the myelin
inhibitors of axon regeneration. Curr. Opin. Neurobiol., 13,
545–551.
4. Fournier,A.E., GrandPre,T. and Strittmatter,S.M. (2001)
Identiﬁcation of a receptor mediating Nogo-66 inhibition of
axonal regeneration. Nature, 409, 341–346.
5. Kim,J.E., Li,S., GrandPre,T., Qiu,D. and Strittmatter,S.M. (2003)
Axon regeneration in young adult mice lacking Nogo-A/B.
Neuron, 38, 187–199.
6. Kuang,E., Wan,Q., Li,X., Xu,H., Zou,T. and Qi,Y. (2006) ER
stress triggers apoptosis induced by Nogo-B/ASY overexpression.
Exp. Cell. Res., 312, 1983–1988.
7. Qi,B., Qi,Y., Watari,A., Yoshioka,N., Inoue,H., Minemoto,Y.,
Yamashita,K., Sasagawa,T. and Yutsudo,M. (2003) Pro-apoptotic
ASY/Nogo-B protein associates with ASYIP. J. Cell. Physiol.,
196, 312–318.
8. Acevedo,L., Yu,J., Erdjument-Bromage,H., Miao,R.Q., Kim,J.E.,
Fulton,D., Tempst,P., Strittmatter,S.M. and Sessa,W.C. (2004) A
new role for Nogo as a regulator of vascular remodeling. Nat.
Med., 10, 382–388.
9. Miao,R.Q., Gao,Y., Harrison,K.D., Prendergast,J., Acevedo,L.M.,
Yu,J., Hu,F., Strittmatter,S.M. and Sessa,W.C. (2006)
Identiﬁcation of a receptor necessary for Nogo-B stimulated
chemotaxis and morphogenesis of endothelial cells. Proc. Natl
Acad. Sci. USA, 103, 10997–11002.
10. Kritz,A.B., Yu,J., Wright,P.L., Wan,S., George,S.J., Halliday,C.,
Kang,N., Sessa,W.C. and Baker,A.H. (2008) In vivo modulation
of Nogo-B attenuates neointima formation. Mol. Ther., 16,
1798–1804.
11. Becker,T., Wullimann,M.F., Becker,C.G., Bernhardt,R.R. and
Schachner,M. (1997) Axonal regrowth after spinal cord
transection in adult zebraﬁsh. J. Comp. Neurol., 377, 577–595.
12. Wanner,M., Lang,D.M., Bandtlow,C.E., Schwab,M.E.,
Bastmeyer,M. and Stuermer,C.A. (1995) Reevaluation of the
growth-permissive substrate properties of goldﬁsh optic nerve
myelin and myelin proteins. J. Neurosci., 15, 7500–7508.
13. Diekmann,H., Klinger,M., Oertle,T., Heinz,D., Pogoda,H.M.,
Schwab,M.E. and Stuermer,C.A. (2005) Analysis of the reticulon
gene family demonstrates the absence of the neurite growth
inhibitor Nogo-A in ﬁsh. Mol. Biol. Evol., 22, 1635–1648.
14. Brosamle,C. and Halpern,M.E. (2009) Nogo-Nogo receptor
signalling in PNS axon outgrowth and pathﬁnding. Mol. Cell.
Neurosci., 40, 401–409.
15. Oertle,T., Huber,C., van der Putten,H. and Schwab,M.E. (2003)
Genomic structure and functional characterisation of the
promoters of human and mouse nogo/rtn4. J. Mol. Biol., 325,
299–323.
16. Westerﬁeld,M. (1995) The Zebraﬁsh Book. University of Oregon
Press, Eugene, OR, USA.
17. Kawakami,K., Takeda,H., Kawakami,N., Kobayashi,M.,
Matsuda,N. and Mishina,M. (2004) A transposon-mediated gene
trap approach identiﬁes developmentally regulated genes in
zebraﬁsh. Dev. Cell., 7, 133–144.
18. Schung,J. and Overton,G.C. (1997), TESS: Transcription Element
Search Software on the WWW, Technical Report
CBIL-TR-1997-1001-v0.0, Computational Biology and Informatics
Laboratory, School of Medicine, University of Pennsylvania.
19. Chou,C.M., Chen,Y.C., Lee,M.T., Chen,G.D., Lu,I.C., Chen,S.T.
and Huang,C.J. (2006) Expression and characterization of a
brain-speciﬁc protein kinase BSK146 from zebraﬁsh. Biochem.
Biophys. Res. Commun., 340, 767–775.
20. Kawakami,K. (2005) Transposon tools and methods in zebraﬁsh.
Dev. Dyn., 234, 244–254.
21. Kawakami,K. (2004) Transgenesis and gene trap methods in
zebraﬁsh by using the Tol2 transposable element. Methods Cell.
Biol., 77, 201–222.
22. Higashijima,S., Okamoto,H., Ueno,N., Hotta,Y. and Eguchi,G.
(1997) High-frequency generation of transgenic zebraﬁsh which
reliably express GFP in whole muscles or the whole body by
using promoters of zebraﬁsh origin. Dev. Biol., 192, 289–299.
23. Chen,Y.C., Cheng,C.H., Chen,G.D., Hung,C.C., Yang,C.H.,
Hwang,S.P., Kawakami,K., Wu,B.K. and Huang,C.J. (2009)
Recapitulation of zebraﬁsh sncga expression pattern and labeling
the habenular complex in transgenic zebraﬁsh using green
ﬂuorescent protein reporter gene. Dev. Dyn., 238, 746–754.
24. Groves,J.A., Hammond,C.L. and Hughes,S.M. (2005) Fgf8 drives
myogenic progression of a novel lateral fast muscle ﬁbre
population in zebraﬁsh. Development, 132, 4211–4222.
25. Hammond,C.L., Hinits,Y., Osborn,D.P., Minchin,J.E.,
Tettamanti,G. and Hughes,S.M. (2007) Signals and myogenic
regulatory factors restrict pax3 and pax7 expression to
dermomyotome-like tissue in zebraﬁsh. Dev. Biol., 302, 504–521.
26. Hinits,Y., Osborn,D.P. and Hughes,S.M. (2009) Diﬀerential
requirements for myogenic regulatory factors distinguish medial
and lateral somitic, cranial and ﬁn muscle ﬁbre populations.
Development, 136, 403–414.
27. Lin,C.Y., Chen,W.T., Lee,H.C., Yang,P.H., Yang,H.J. and
Tsai,H.J. (2009) The transcription factor Six1a plays an essential
role in the craniofacial myogenesis of zebraﬁsh. Dev. Biol., 331,
152–166.
28. Schnapp,E., Pistocchi,A.S., Karampetsou,E., Foglia,E.,
Lamia,C.L., Cotelli,F. and Cossu,G. (2009) Induced early
expression of mrf4 but not myog rescues myogenesis in the
myod/myf5 double-morphant zebraﬁsh embryo. J. Cell. Sci., 122,
481–488.
29. Chen,M.S., Huber,A.B., van der Haar,M.E., Frank,M.,
Schnell,L., Spillmann,A.A., Christ,F. and Schwab,M.E. (2000)
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an
antigen for monoclonal antibody IN-1. Nature, 403, 434–439.
30. Apone,S. and Hauschka,S.D. (1995) Muscle gene E-box control
elements. Evidence for quantitatively diﬀerent transcriptional
activities and the binding of distinct regulatory factors.
J. Biol. Chem., 270, 21420–21427.
31. Amacher,S.L., Buskin,J.N. and Hauschka,S.D. (1993) Multiple
regulatory elements contribute diﬀerentially to muscle creatine
kinase enhancer activity in skeletal and cardiac muscle.
Mol. Cell. Biol., 13, 2753–2764.
32. Rao,M.V., Donoghue,M.J., Merlie,J.P. and Sanes,J.R. (1996)
Distinct regulatory elements control muscle-speciﬁc,
ﬁber-type-selective, and axially graded expression of a myosin
light-chain gene in transgenic mice. Mol. Cell. Biol., 16,
3909–3922.
33. McKinsey,T.A., Zhang,C.L. and Olson,E.N. (2002) MEF2: a
calcium-dependent regulator of cell division, diﬀerentiation and
death. Trends Biochem. Sci., 27, 40–47.
34. Black,B.L. and Olson,E.N. (1998) Transcriptional control of
muscle development by myocyte enhancer factor-2 (MEF2)
proteins. Annu. Rev. Cell. Dev. Biol., 14, 167–196.
35. Ticho,B.S., Stainier,D.Y., Fishman,M.C. and Breitbart,R.E.
(1996) Three zebraﬁsh MEF2 genes delineate somitic and cardiac
muscle development in wild-type and mutant embryos. Mech.
Dev., 59, 205–218.
36. Hu,F., Liu,B.P., Budel,S., Liao,J., Chin,J., Fournier,A. and
Strittmatter,S.M. (2005) Nogo-A interacts with the Nogo-66
receptor through multiple sites to create an isoform-selective
subnanomolar agonist. J. Neurosci., 25, 5298–5304.
37. Klinger,M., Taylor,J.S., Oertle,T., Schwab,M.E., Stuermer,C.A.
and Diekmann,H. (2004) Identiﬁcation of Nogo-66 receptor
(NgR) and homologous genes in ﬁsh. Mol. Biol. Evol., 21, 76–85.
38. Pare,J.F., Roy,S., Galarneau,L. and Belanger,L. (2001) The
mouse fetoprotein transcription factor (FTF) gene promoter is
regulated by three GATA elements with tandem E box and Nkx
motifs, and FTF in turn activates the Hnf3beta, Hnf4alpha, and
Hnf1alpha gene promoters. J. Biol. Chem., 276, 13136–13144.
39. Kato,T., Katabami,K., Takatsuki,H., Han,S.A., Takeuchi,K.,
Irimura,T. and Tsuji,T. (2002) Characterization of the promoter
for the mouse alpha 3 integrin gene. Eur. J. Biochem., 269,
4524–4532.
40. Holtzinger,A. and Evans,T. (2005) Gata4 regulates the formation
of multiple organs. Development, 132, 4005–4014.
Nucleic Acids Research, 2010,Vol.38, No. 14 464941. Reiter,J.F., Alexander,J., Rodaway,A., Yelon,D., Patient,R.,
Holder,N. and Stainier,D.Y. (1999) Gata5 is required for the
development of the heart and endoderm in zebraﬁsh. Genes Dev.,
13, 2983–2995.
42. Reiter,J.F., Kikuchi,Y. and Stainier,D.Y. (2001) Multiple roles for
Gata5 in zebraﬁsh endoderm formation. Development, 128,
125–135.
43. Zhao,R., Watt,A.J., Li,J., Luebke-Wheeler,J., Morrisey,E.E. and
Duncan,S.A. (2005) GATA6 is essential for embryonic
development of the liver but dispensable for early heart
formation. Mol. Cell. Biol., 25, 2622–2631.
44. Josephson,A., Trifunovski,A., Widmer,H.R., Widenfalk,J.,
Olson,L. and Spenger,C. (2002) Nogo-receptor gene activity:
cellular localization and developmental regulation of mRNA in
mice and humans. J. Comp. Neurol., 453, 292–304.
45. Her,G.M., Chiang,C.C., Chen,W.Y. and Wu,J.L. (2003) In vivo
studies of liver-type fatty acid binding protein (L-FABP) gene
expression in liver of transgenic zebraﬁsh. FEBS Lett., 538,
125–133.
46. Her,G.M., Chiang,C.C. and Wu,J.L. (2004) Zebraﬁsh intestinal
fatty acid binding protein (I-FABP) gene promoter drives
gut-speciﬁc expression in stable transgenic ﬁsh. Genesis, 38, 26–31.
47. Morrisey,E.E., Tang,Z., Sigrist,K., Lu,M.M., Jiang,F., Ip,H.S.
and Parmacek,M.S. (1998) GATA6 regulates HNF4 and is
required for diﬀerentiation of visceral endoderm in the mouse
embryo. Genes Dev., 12, 3579–3590.
48. Andre,M., Ando,S., Ballagny,C., Durliat,M., Poupard,G.,
Briancon,C. and Babin,P.J. (2000) Intestinal fatty acid binding
protein gene expression reveals the cephalocaudal patterning
during zebraﬁsh gut morphogenesis. Int. J. Dev. Biol., 44,
249–252.
49. Denovan-Wright,E.M., Pierce,M., Sharma,M.K. and Wright,J.M.
(2000) cDNA sequence and tissue-speciﬁc expression of a basic
liver-type fatty acid binding protein in adult zebraﬁsh. Biochim.
Biophys. Acta., 1492, 227–232.
50. Liu,R.Z., Denovan-Wright,E.M., Degrave,A., Thisse,C., Thisse,B.
and Wright,J.M. (2004) Diﬀerential expression of duplicated genes
for brain-type fatty acid-binding proteins (fabp7a and fabp7b)
during early development of the CNS in zebraﬁsh. Gene Expr.
Patterns, 4, 379–387.
51. Liu,R.Z., Denovan-Wright,E.M. and Wright,J.M. (2003)
Structure, linkage mapping and expression of the heart-type fatty
acid-binding protein gene (fabp3) from zebraﬁsh.
Eur. J. Biochem., 270, 3223–3234.
52. Pierce,M., Wang,Y., Denovan-Wright,E.M. and Wright,J.M.
(2000) Nucleotide sequence of a cDNA clone coding for an
intestinal-type fatty acid binding protein and its tissue-speciﬁc
expression in zebraﬁsh. Biochim. Biophys. Acta., 1490, 175–183.
4650 Nucleic Acids Research, 2010,Vol.38, No. 14